These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3832745

  • 1. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W, Gastl G, Troppmair J, Tilg H, Abbrederis K, Nerl C, Flener R, Rokos H, Huber C.
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [Abstract] [Full Text] [Related]

  • 2. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G, Werter M, De Pauw B, Nerl C, Aulitzky W, von Lüttichau I, Tilg H, Thaler J, Lang A, Abbrederis K.
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [Abstract] [Full Text] [Related]

  • 3. A biological approach to optimize interferon treatment in hairy cell leukemia.
    Gastl G, Aulitzky W, Tilg H, Nachbaur K, Troppmair J, Flener R, Huber C.
    Immunobiology; 1986 Sep; 172(3-5):262-8. PubMed ID: 3804368
    [Abstract] [Full Text] [Related]

  • 4. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W, Gastl G, Tilg H, Troppmair J, Leiter E, Geissler D, Flener R, Huber C.
    Wien Med Wochenschr; 1986 Apr 30; 136(7-8):172-81. PubMed ID: 3524022
    [Abstract] [Full Text] [Related]

  • 5. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Apr 30; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 6. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C, Aulitzky W, Tilg H, von Lüttichau I, Troppmair J, Nachbauer K, Gastl G.
    Leukemia; 1987 Apr 30; 1(4):355-7. PubMed ID: 3669762
    [Abstract] [Full Text] [Related]

  • 7. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I, Bettelheim P, Chott A, Herold C, Hinterberger W, Köller U, Kos M, Neumann E, Radaszkiewicz T, Lechner K.
    Wien Klin Wochenschr; 1988 Jan 22; 100(2):47-51. PubMed ID: 3348041
    [Abstract] [Full Text] [Related]

  • 8. [Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia].
    Hofmann V, Scheel A, Schwarzmeier J, Talstad I, Varini M, Kaplan S, Sauter C, Fehr J.
    Schweiz Med Wochenschr; 1985 Feb 16; 115(7):235-8. PubMed ID: 3872477
    [Abstract] [Full Text] [Related]

  • 9. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb 16; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 10. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
    Mirro J, Dow LW, Kalwinsky DK, Dahl GV, Weck P, Whisnant J, Murphy SB.
    Cancer Treat Rep; 1986 Mar 16; 70(3):363-7. PubMed ID: 3456833
    [Abstract] [Full Text] [Related]

  • 11. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 Mar 16; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 12. Hairy cell leukemia: a model for studying the B cell family of diseases.
    Al-Katib A, Berman E, Black P, Koziner B.
    Semin Oncol; 1986 Dec 16; 13(4 Suppl 5):48-54. PubMed ID: 3492047
    [Abstract] [Full Text] [Related]

  • 13. Phase I evaluation of a synthetic mutant of beta-interferon.
    Hawkins M, Horning S, Konrad M, Anderson S, Sielaff K, Rosno S, Schiesel J, Davis T, DeMets D, Merigan T.
    Cancer Res; 1985 Nov 16; 45(11 Pt 2):5914-20. PubMed ID: 4053062
    [Abstract] [Full Text] [Related]

  • 14. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA, Brady J, Kidd P, Fefer A.
    Cancer Treat Rep; 1985 Nov 16; 69(7-8):791-3. PubMed ID: 4016788
    [Abstract] [Full Text] [Related]

  • 15. Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2.
    Brown RR, Lee CM, Kohler PC, Hank JA, Storer BE, Sondel PM.
    Cancer Res; 1989 Sep 01; 49(17):4941-4. PubMed ID: 2788032
    [Abstract] [Full Text] [Related]

  • 16. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Sep 01; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 17. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D, Levo Y, Rahmani R, Mory Y, Vaks B, Horowitz O, Doerner T, Shoham J, Wallach D, Revel M.
    Isr J Med Sci; 1985 Dec 01; 21(12):977-81. PubMed ID: 4093298
    [Abstract] [Full Text] [Related]

  • 18. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ, Bogman MJ, Janssen JT, de Pauw BE, Haanen CA.
    Ned Tijdschr Geneeskd; 1987 Nov 14; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract] [Full Text] [Related]

  • 19. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V, Fehr J, Sauter C, Ottino J.
    Cancer Treat Rev; 1985 Dec 14; 12 Suppl B():33-7. PubMed ID: 3833328
    [Abstract] [Full Text] [Related]

  • 20. Effects of interferon-alpha on macrophage activation in patients with ovarian carcinoma and cervical dysplasia.
    Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, Wachter H.
    J Clin Lab Immunol; 1989 Jun 14; 29(2):65-9. PubMed ID: 2632803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.